http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008523805-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-099 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10 |
| filingDate | 2005-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008523805-A |
| titleOfInvention | Deacylation of LPS in Gram-negative bacteria |
| abstract | The present invention provides a novel gram-negative polypeptide that exhibits lipid A3-O-deacylase activity and is capable of modifying and / or detoxifying gram-negative LPS. The present invention also comprises the 3-O-deacylase activity described in the present invention, or has been treated with said activity, for pharmaceutical and / or veterinary purposes, in particular pertussis, parapertussis And a composition comprising gram-negative bacteria, gram-negative lipopolysaccharide (LPS) and LPS, which can be used to prepare whole cell or cell-free vaccines against pathogenic gram-negative bacteria such as bronchial septic bacteria. is there. |
| priorityDate | 2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.